ELTROMBOPAG DR.REDDY'S (Dr Reddys Laboratories Australia Pty Ltd)

[TRADE NAME] is indicated for the treatment of:

• paediatric patients with chronic immune thrombocytopaenia (ITP) who have failed other treatments and either (a) need an increased platelet concentration for a planned procedure or (b) are at a high risk of bleeding;
• adult patients with chronic ITP who have had an inadequate response or are intolerant to corticosteroids and immunoglobulins;
• thrombocytopenia in adult patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy;